CALYPTE BIOMEDICAL CORP Debt Conversion, Converted Instrument, Amount
CALYPTE BIOMEDICAL CORP reported Debt Conversion, Converted Instrument, Amount of $914.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2014-06-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2014-06-24
- CALYPTE BIOMEDICAL CORP debt conversion, converted instrument, amount for the quarter ending 2012-12-31 was $0.00.
- CALYPTE BIOMEDICAL CORP debt conversion, converted instrument, amount for the quarter ending 2012-09-30 was $0.00.
- CALYPTE BIOMEDICAL CORP debt conversion, converted instrument, amount for the quarter ending 2012-06-30 was $0.00.
- CALYPTE BIOMEDICAL CORP debt conversion, converted instrument, amount for the quarter ending 2012-03-31 was $914.00K.
- CALYPTE BIOMEDICAL CORP debt conversion, converted instrument, amount for fiscal 2012 was $914.00K.
- CALYPTE BIOMEDICAL CORP debt conversion, converted instrument, amount for fiscal 2010 was $377.00K.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-24 | $0.00 derived: sum of 2 quarters · filed 2014-06-24 | $0.00 derived: sum of 3 quarters · filed 2014-06-24 | $914.00K 10-K · filed 2014-06-24 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-12-31 | $0.00 derived: sum of 2 quarters · filed 2012-12-31 | $914.00K 10-Q · filed 2012-12-31 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $914.00K 10-Q · filed 2012-08-14 | ||
| 2012-03-31 | $914.00K 10-Q · filed 2012-05-15 | |||
| 2010-12-31 | -$914.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-22 | $249.00K derived: sum of 2 quarters · filed 2012-03-22 | $377.00K 10-K · filed 2012-03-22 | |
| 2010-09-30 | $1.16M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-01-27 | $1.29M 10-Q · filed 2012-01-27 | ||
| 2010-06-30 | $128.00K 10-Q/A · filed 2011-11-30 |